Buscador de publicaciones

Publicaciones

  • Amat-Bou M, Garcia-Ribera S, Climent E, Piquer-Garcia I, Corripio R, Sánchez-Infantes D, Villalta L, MARIA ELIAS ABADIAS, Jimenez-Chillaron JC, Chenoll E, Ramón D, Ibañez-Toda L, Ramon-Krauel M and Lerin C.

    Effects of Bifidobacterium animalis Subsp.lactis (BPL1) Supplementation in Children and Adolescents with Prader-Willi Syndrome: A Randomized Crossover Trial

    Nutrients . 12(10): 3123. Nº de citas: 12

    [doi:10.3390/nu12103123]

  • Ibañez-Toda L, Díaz-Silva M, García-Beltran C, Malpique R, Garde E, López-Bermejo A and de Zegher F.

    Toward a Treatment Normalizing Ovulation Rate in Adolescent Girls With Polycystic Ovary Syndrome

    Journal of the Endocrine Society . 4(5): . Nº de citas: 23

    [doi:10.1210/jendso/bvaa032]

  • Garcia-Ribera S, Amat-Bou M, Climent E, Llobet-Garcès M, Chenoll E, Corripio R, Ibañez-Toda L, Ramon-Krauel M and Lerin C.

    Specific Dietary Components and Gut Microbiota Composition are Associated with Obesity in Children and Adolescents with Prader-Willi Syndrome

    Nutrients . 12(4): 1063. Nº de citas: 15

    [doi:10.3390/nu12041063]

  • Díaz-Silva M, Campderrós L, Guimaraes MP, López-Bermejo A, de Zegher F, Villarroya-Gombau F and Ibañez-Toda L.

    Circulating growth-and-differentiation factor-15 in early life: relation to prenatal and postnatal growth and adiposity measurements

    PEDIATRIC RESEARCH . 87(5): 897-902. Nº de citas: 22

    [doi:10.1038/s41390-019-0633-z]

  • Díaz-Silva M, Bassols J, López-Bermejo A, de Zegher F and Ibañez-Toda L.

    Low Circulating Levels of miR-451a in Girls with Polycystic Ovary Syndrome: Different Effects of Randomized Treatments

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 105(3): 273-281. Nº de citas: 15

    [doi:10.1210/clinem/dgz204]

  • Xargay S, Dorado-Ceballos E, Benavides-Boixader A, Lizárraga-Mollinedo E, Mas-Parés B, Montesinos-Costa M, De Zegher F, Ibañez-Toda L, Bassols J and López-Bermejo A.

    Circulating IGF-1 Independently Predicts Blood Pressure in Children With Higher Calcium-Phosphorus Product Levels

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 105(3): 610-618. Nº de citas: 4

    [doi:10.1210/clinem/dgz101]

  • Binder G, Reinehr T, Ibañez-Toda L, Thiele S, Linglart A, Woelfle J, Saenger P, Bettendorf M, Zachurzok A, Gohlke B, Randell T, Hauffa BP, Claahsen van der Grinten HL, Holterhus PM, Juul A, Pfäffle R and Cianfarani S.

    GHD Diagnostics in Europe and the US: An Audit of National Guidelines and Practice

    HORMONE RESEARCH IN PAEDIATRICS . 92(3): 150-156. Nº de citas: 38

    [doi:10.1159/000503783]

  • Ibañez-Toda L and de Zegher F.

    Polycystic ovary syndrome in adolescent girls

    PEDIATRIC OBESITY . 15(2): . Nº de citas: 16

    [doi:10.1111/ijpo.12586]

  • Díaz-Silva M, Garde E, López-Bermejo A, de Zegher F and Ibañez-Toda L.

    Differential DNA methylation profile in infants born small-for-gestational-age: association with markers of adiposity and insulin resistance from birth to age 24 months

    BMJ OPEN DIABETES RESEARCH & CARE . 8(1): 1402-1402. Nº de citas: 16

    [doi:10.1136/bmjdrc-2020-001402]

  • García-Beltran C, Cereijo R, Quesada T, Malpique R, López-Bermejo A, de Zegher F, Ibañez-Toda L and Villarroya-Gombau F.

    Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization

    BMJ OPEN DIABETES RESEARCH & CARE . 8(1): . Nº de citas: 21

    [doi:10.1136/bmjdrc-2019-001035]